# Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use

> **NCT02977208** · PHASE4 · COMPLETED · sponsor: **São Paulo State University** · enrollment: 66 (actual)

## Conditions studied

- Epilepsy
- Chronic Pain

## Interventions

- **PROCEDURE:** Sparse blood sampling
- **PROCEDURE:** Urine sampling
- **PROCEDURE:** DNA extraction
- **DRUG:** Gabapentin

## Key facts

- **NCT ID:** NCT02977208
- **Lead sponsor:** São Paulo State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2018-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02977208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02977208, "Impact of Polymorphisms of OCT2 and OCTN1 on the Kinetic Disposition of Gabapentin in Patients Undergoing Chronic Use". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02977208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*